Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 695-953-8 | CAS number: 204918-22-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- prop-2-en-1-yl 2-(2-chloro-5-isocyanatobenzoyloxy)-2-methylpropanoate
- EC Number:
- 695-953-8
- Cas Number:
- 204918-22-9
- Molecular formula:
- C15H14ClNO5
- IUPAC Name:
- prop-2-en-1-yl 2-(2-chloro-5-isocyanatobenzoyloxy)-2-methylpropanoate
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Himalayan
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd. Biotechnology & Animal Breeding Division, Wölferstrasse 4, CH-4414 Füllinsdorf / Switzerland
- Age at study initiation: 4 - 6 weeks
- Weight at study initiation: (pre-test group) Males: 356 - 398 g Females: 304 - 351 g
(control and test groups( Males: 316 - 371 g Females: 298 - 402 g
- Housing: Individual
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature: 20 - 22.5°C
- Humidity: 47 - 73 %
- Air changes: 10 - 15/hour
- Photoperiod: 12 hours light/12 hours datk
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- peanut oil
- Concentration / amount:
- Intradermal induction (day 1): 5 %
Epidermal induction (day 8): 100 %
Epidermal application (day 18): 0.5 %
Challengeopen allclose all
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- peanut oil
- Concentration / amount:
- Intradermal induction (day 1): 5 %
Epidermal induction (day 8): 100 %
Epidermal application (day 18): 0.5 %
- No. of animals per dose:
- Control group: 5 Male, 5 Female
Test group: 10 Male, 10 Female - Details on study design:
- RANGE FINDING TESTS:
PRE-TESTS
The intradermal and epidermal pre-test I were performed with the test material before and during acclimatization period of the control and test group.
The epidermal pre-test II was performed during the intradermal and epidermal induction of the control and test group.
The epidermal pre-test III was performed after the epidermal induction of the control and test group.
The second and third pre- tests (to determine the concentration for epidermal challenge) were necessary due to findings of irritation at successively lower concentrations in the epidermal pre-test I.
PRE-TESTS - INTRADERMAL INJECTIONS
Four intradermal injections (0.1ml/site) of a 1:1 (v/v) mixture of FCA/physiological saline were made into the shaved neck of one guinea pig. One week later intradermal injections (0.1ml/site) were made into the clipped flank of the same guinea pig at concentrations of 5%, 3% and 1%. of the test item in the vehicle.
Dermal reactions were assessed after a 24 hour period.
EPIDERMAL APPLICATION – EPIDERMAL PRE-TEST I
Four intradermal injections (0.1ml/site) of a 1:1 (v/v) mixture of FCA/physiological saline were made into the shaved neck of two guinea pigs. One week later both flanks of each of the guinea pigs were clipped and shaved just prior to the application.
Thereafter 4 patches of filter paper (3x3cm) were saturated with the test item at 1005, 75%, 50% and 25% and applied to the clipped and shaved flanks. Vehicle was used for dilution. The volume of test item preparation applied was approximately 0.2ml. The patches were covered by a strip of aluminium foil and firmly secured by plastic plaster wrapped around the trunk and covered with impervious adhesive tape. This procedure ensured the intensive contact of the test item.
The dressings were removed after an exposure period of 24 hours.
The reaction sites were assessed 24 and 48 hours after removal of the bandage for erythema and oedema.
EPIDERMAL APPLICATION – EPIDERMAL PRE-TEST II
As no highest non-irritating concentration could be determined after the epidermal pre-test, a second epidermal pre-test was performed with two additional naïve guinea pigs. The animals were pre-treated with FCA/saline and treated in the same way as those described previously, with the concentrations of 15%, 10%, 5% and 1% in vehicle, also using an application of approximately 0.2ml.
The reaction sites were assessed 24 and 48 hours after removal of the bandage for erythema and oedema.
EPIDERMAL APPLICATION – EPIDERMAL PRE-TEST III
As no highest non-irritating concentration was determined in the second epidermal pre-teat, a third epidermal pre-test was conducted with two additional naïve guinea pigs pre-treated with FCA/saline as previously (only five days between pre-treatment and treatment) and treated epidermally with the concentrations of 0.5%, 0.1%, 0.05% and 0.01% in vehicle. An application volume of approximately 0.2ml was used.
The reaction sites were assessed 24 and 48 hours after removal of the bandage for erythema and oedema.
SELECTION OF CONCENTRATIONS FOR THE MAIN STUDY:
INTRADERMAL INDUCTION
The 5% concentration of the test item selected for the induction exposure was well tolerated systemically and caused mild to moderate skin irritation. Higher concentrations were not tested because the 5% concentration is the maximum concentration for intradermal induction recommended.
EPIDERMAL INDUCTION
The 100% concentration of the test item used for the induction exposure was the highest concentration Causing mild to moderate skin irritation. It was well tolerated systemically.
EPIDEMAL CHALLENGE
The 0.5% concentration of the test item used for the challenge application was the highest tested non-irritant concentration.
From the observed findings the test item at 100% was considered to be the tolerated concentration to stimulate a state of immune hypersensitivity and 0.5% as the highest non-irritating concentration to be used for the challenge.
MAIN STUDY
A. INDUCTION EXPOSURE
INDUCTION
INTRADERMAL INJECTIONS – TEST DAY 1
An area of dorsal skin from the scapular region (approx. 6x8cm) was clipped free of hair. Three pairs of intradermal injections (0.1ml/site) were made at the border of a 4x4cm area clipped region as follows:
Test group
1) 1:1 (v/v) mixture of FCA and physiological saline.
2) The test item at 5 % in the vehicle
3) The test item at 5% in a 1:1 (v/v) mixture of FCA and physiological saline.
Control group
1) 1:1 (v/v) mixture of FCA/physiological saline.
2) The vehicle alone.
3) 1:1 (w/w) mixture of the vehicle and a 1:1 (v/v) mixture of FCA and physiological saline.
EPIDERMAL APPLICATIONS – TEST DAY 8
On test day 8, a 2x4cm patch of filter paper was saturated with the undiluted test item and placed on the shaved area over the injection sites of the test animals. The volume of test item preparation applied was approximately 0.3ml. The patch was covered with aluminium foil and firmly secured by an elastic plaster wrapped around the trunk of the animal and secured with impervious adhesive tape. The occlusive dressings were left in place for 48 hours. This procedure ensures intensive contact of the test item.
The guinea pigs of the control group were treated as described above with the vehicle only, also applied at a volume of approximately 0.3ml.
B. CHALLENGE EXPOSURE
CHALLENGE – TEST DAY 25
The test and control guinea pigs were challenged 17 days after the epidermal induction application and were treated in the same way.
Hair was clipped and shaved from a 5x5cm area on the left and right flank of each guinea pig just prior to the application. Two patches (3x3cm) of filter paper were saturated with the test item at the highest tested non-irritating concentration of 0.5% (applied to the left flank) and the vehicle only (applied to the right flank) using the same method as for the epidermal application. The volume of test item preparation and vehicle applied was approximately 0.2ml.
The dressings were left in place for 24 hours.
The reaction sites were assessed 24 and 48 hours after removal of the bandage for erythema and oedema. - Positive control substance(s):
- yes
- Remarks:
- alpha-hexylcinnamaldehyde
Results and discussion
- Positive control results:
-
For results refer to Table 4.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: Control
- Dose level:
- 0.5%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: Control. Dose level: 0.5%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: Control
- Dose level:
- 0.5%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: Control. Dose level: 0.5%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0.5%
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0.5%. No with. + reactions: 20.0. Total no. in groups: 20.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.5%
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.5%. No with. + reactions: 20.0. Total no. in groups: 20.0.
Any other information on results incl. tables
Results for the test item
Skin Reactions after the Challenge Procedure
|
After 24 hours |
After 48 hours |
|
|
Positive / Total__ % Positive of Total
|
Positive / Total__ % Positive of Total
|
|
Control Group |
Test Item, 0.5 % in vehicle (left flank) |
0 / 10 0 |
0 / 10 0 |
Vehicle only (right flank) |
0 / 10 0 |
0 / 10 0 |
|
Test Group |
Test Item, 0.5 % in vehicle (left flank) |
20 / 20 100 |
20 / 20 100 |
Vehicle only (right flank) |
0 / 20 0 |
0 / 20 0 |
Table 4
Positive Control – Skin Reactions after the Challenge Procedure
|
After 24 hours |
After 48 hours |
|
|
Positive / Total__ % Positive of Total
|
Positive / Total__ % Positive of Total
|
|
Control Group |
Alpha-hexylcinnamaldehyde, 1 % in PEG 300 (left flank) |
0 / 5 0 |
0 / 5 0 |
PEG 300 only (right flank) |
0 / 5 0 |
0 / 5 0 |
|
Test Group |
Alpha-hexylcinnamaldehyde, 1 % in PEG 300 (left flank) |
7 / 10 70 |
5 / 10 50 |
PEG 300 only (right flank) |
0 / 10 0 |
0 / 10 0 |
Applicant's summary and conclusion
- Interpretation of results:
- other: May cause sensitization by skin contact
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- Conclusion
The 100 % incidence of challenge skin reactions to the test item is above the threshold (30 % for adjuvant test) set in Commission Directive 96/54/EEC. Therefore, CA 2814 B (Intermediate of CGA 276854) is required to be classified as ‘May cause sensitization by skin contact’. - Executive summary:
In order to assess the cutaneous allergenic potential of CA 2814 B (Intermediate of CGA 276854), the Maximisation-Test was performed in 5 male and 5 female control and 10 male and 10 female test albino guinea pigs, in accordance with OECD Guideline NO. 406 and Directive 96/54/EEC, B.6.
The intradermal induction of the test group animals was performed with 5 % concentrations of the test item in the vehicle (peanut oil) and in Freund’s Complete Adjuvant (FCA) (as 1:1 FCA in physiological saline). Control group animals were injected with the vehicle alone and FCA/physiological saline alone. Beginning on study day 8, the epidermal induction was conducted for 48 hours with 100 % concentration of the test item (test group animals) or vehicle alone (control group animals). Seventeen days after epidermal induction, the control and test animals were challenged by epidermal application of the test item at 0.5 % in the vehicle and the vehicle alone. Cutaneous reactions evaluated 24 and 48 hours after removal of the dressing.
Results
Skin Reactions after the Challenge Procedure
After 24 hours
After 48 hours
Positive / Total__
% Positive of Total
Positive / Total__
% Positive of Total
Control Group
Test Item, 0.5 % in vehicle
(left flank)
0 / 10
0
0 / 10
0
Vehicle only
(right flank)
0 / 10
0
0 / 10
0
Test Group
Test Item, 0.5 % in vehicle
(left flank)
20 / 20
100
20 / 20
100
Vehicle only
(right flank)
0 / 20
0
0 / 20
0
All test animals showed discrete/patchy to moderate/confluent erythema at the 24- and 48-hour reading after the challenge treatment with CA 2814 B (Intermediate of GCA 276854) at 0.5 % (w/w) in the vehicle. No skin effect was observed in the control group.
No toxic symptoms were evident in the guinea pigs of the control or test group.
No deaths occurred.
Conclusion
The 100 % incidence of challenge skin reactions to the test item is above the threshold (30 % for adjuvant test) set in Commission Directive 96/54/EEC. Therefore, CA 2814 B (Intermediate of CGA 276854) is required to be classified as ‘May cause sensitization by skin contact’.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.